These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14347877)

  • 1. [FIBRINOLYTIC ACTIVITY OF COMMERCIAL THROMBINS AND THEIR INFLUENCE ON THE ACCURACY OF THE STANDARD FIBRIN PLATE METHOD].
    SCHULTE W
    Thromb Diath Haemorrh; 1965 Jun; 13():561-71. PubMed ID: 14347877
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in the mechanism of blood clot formation and nanostructure in infants and children compared with adults.
    Ignjatovic V; Pelkmans L; Kelchtermans H; Al Dieri R; Hemker C; Kremers R; Bloemen S; Karlaftis V; Attard C; de Laat B; Monagle P
    Thromb Res; 2015 Dec; 136(6):1303-9. PubMed ID: 26522267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Overall Hemostatic Potential (OHP) Assay.
    Curnow J
    Methods Mol Biol; 2017; 1646():523-531. PubMed ID: 28804852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [THROMBOLYSIS: DIRECT DETERMINATION OF FIBRINOLYTIC SUBSTANCES BY MEANS OF STATIC RETRACTROMETRY].
    SCHULTE W
    Thromb Diath Haemorrh; 1964 Oct; 12():282-94. PubMed ID: 14224639
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No increased systemic fibrinolysis in women with heavy menstrual bleeding.
    Wiewel-Verschueren S; Knol HM; Lisman T; Bogchelman DH; Kluin-Nelemans JC; van der Zee AG; Mulder AB; Meijer K
    J Thromb Haemost; 2014 Sep; 12(9):1488-93. PubMed ID: 24954113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.
    Colucci M; Incampo F; Cannavò A; Menegatti M; Siboni SM; Zaccaria F; Semeraro N; Peyvandi F
    J Thromb Haemost; 2016 Aug; 14(8):1603-14. PubMed ID: 27094709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE.
    BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A
    Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046
    [No Abstract]   [Full Text] [Related]  

  • 13. [The TAFI system. The new role of fibrinolysis].
    Dempfle CE
    Hamostaseologie; 2007 Sep; 27(4):278-81. PubMed ID: 17938767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic agents and their effects on the haemostatic system.
    Kluft C
    Klin Wochenschr; 1988; 66 Suppl 12():50-4. PubMed ID: 2964542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The plasminogen (fibrinolytic) system.
    Collen D
    Thromb Haemost; 1999 Aug; 82(2):259-70. PubMed ID: 10605712
    [No Abstract]   [Full Text] [Related]  

  • 16. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
    Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts.
    Zhalyalov AS; Panteleev MA; Gracheva MA; Ataullakhanov FI; Shibeko AM
    PLoS One; 2017; 12(7):e0180668. PubMed ID: 28686711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fibrinolytic enzyme defect of hyaline membrane disease.
    LIEBERMAN J; KELLOGG F
    Calif Med; 1961 Nov; 95(5):278-82. PubMed ID: 14465183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LOCALIZATION OF FIBRINOLYTIC ACTIVITY IN MYOCARDIAL INFARCTS IN RATS.
    KWAAN HC; ASTRUP T
    Thromb Diath Haemorrh; 1964 Dec; 12():407-17. PubMed ID: 14254700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.